northpointe capital llc  top money managers northpointe capital llc  bloomfield hills  mi  company information products resources my account talk to a db advisor  business directory mi bloomfield hills real estate investment trusts real estate investment trusts northpointe capital llc n northpointe capital llc claim this business  woodward ave   bloomfield hills mi  get directions   wwwnorthpointecapitalcom business info founded  incorporated annual revenue  employee count  industries real estate investment trusts contacts michael p hayden contact business your email address subject message send message company summary northpointe capital llc was founded in  and is located at  woodward ave   in bloomfield hills additional information is available at wwwnorthpointecapitalcom or by contacting michael p hayden at   verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   n view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved disclosures  northpointe capital northpointe capital disclosures home  disclosures past performance is not necessarily indicative of future results performance returns are presented gross and net of fees please see attached gips presentation for additional disclosures and composite information northpointe capital® llc northpointe located in bloomfield hiils michigan is an asset management firm northpointe is a registered investment adviser with the securities and exchange commission and provides investment management services to institutional investors through separate accounts mutual funds and wrap accounts concentrated small cap equity composite inceptioncreation date of october   uses core style of equity portfolio management with a market cap range similar to the russell ® index with no minimum account size northpointe calculates performance results using a daily time weighted rate of return and for the monthly calculation we geometrically link all the daily returns to get the monthly return this takes out any effect of a cash flow during the month the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees which includes performance fees all performance shown reflects trade execution costs and assumes the reinvestment of dividends and capital gains percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized large cap value equity composite inceptioncreation date is june   uses a value style of equity portfolio management with a market cap range similar to the russell ® value index with no minimum account size prior to september   the minimum account size for the composite was  million northpointe calculates performance results using a daily time weighted rate of return and for the monthly calculation we geometrically link all the daily returns to get the monthly return this takes out any effect of a cash flow during the month the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period effective april   composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy prior monthly periods reflect a policy of at least one full reporting period under management before a new portfolio would be added to the composite returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees and includes the reinvestment of all income and trade execution costs  percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized effective  the disciplined large cap value equity composite changed its name to large cap value equity there have been no changes in the process philosophy or team only a change of name the composite consisted of one nonfee paying account which represented  of the composite’s assets for  and  of the composite’s assets in  this account represented seed money invested in the large cap value strategy no fees were charged since money represents internal funds see standard fee schedule for fees charged for this product as of april   the seed money investment was removed from the composite since the account was liquidated a complete list and description of all composites maintained by northpointe and the related performance results as well as additional information regarding policies for valuing portfolios calculating performance and preparing compliant presentations are available upon request micro cap value equity composite inceptioncreation date of january   focuses on emerging companies with a market cap range similar to the russell microcap® index with no minimum account size northpointe calculates performance results using a daily time weighted rate of return and for the monthly calculation we geometrically link all the daily returns to get the monthly return this takes out any effect of a cash flow during the month the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees which includes performance fees and includes the reinvestment of all income and trade execution costs for the periods between  and   of composite assets are nonfee paying for the year ending   of composite assets are nonfee paying this account represents seed money invested in the micro cap value strategy no fees were charged since money represented internal funds see standard fee schedule for fees charged for this product all performance shown reflects trade execution costs and assumes the reinvestment of dividends and capital gains percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized small cap core equity composite inceptioncreation date of january   uses a core style of equity portfolio management with a market cap range similar to the russell ® index with no minimum account size prior to september   the minimum account size for the composite was  million northpointe calculates performance results using a daily time weighted rate of return and for the monthly calculation we geometrically link all the daily returns to get the monthly return this takes out any effect of a cash flow during the month the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees and includes the reinvestment of all income and trade execution costs  for the periods between  and  the composite assets held  nonfee paying accounts for the quarter ending   of composite assets are nonfee paying for the year ending   of composite assets are nonfee paying for the year ending   of composite assets are nonfee paying and for the year ending   of composite assets are nonfee paying percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized small cap value equity composite inceptioncreation date of january   uses a value style of equity portfolio management where portfolios have a weighted average market cap similar to the russell ® value index with no minimum account size prior to september   the minimum account size for the composite was  million as of  the composite was redefined to include accounts managed in the smid mandate to further broaden the strategy northpointe calculates performance results using a daily time weighted rate of return and for the monthly calculation we geometrically link all the daily returns to get the monthly return this takes out any effect of a cash flow during the month the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period effective april   composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy prior monthly periods reflect a policy of at least one full reporting period under management before a new portfolio would be added to the composite returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees and includes the reinvestment of all income and trade execution costs  percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized as of   of composite are non fee paying smid cap value equity composite inceptioncreation date of january   uses a value style of equity portfolio management with a market cap range similar to the russell ® value index with no minimum account size prior to september   the minimum account size for the composite was  million northpointe calculates performance results using a timeweighted monthly linked percentage return formula with appropriate adjustments for any cash flows the quarterly composite calculation appropriately weights portfolio returns for the size of each portfolio using balances as of the beginning of the monthly reporting period effective april   composites will include new portfolios at the start of the first performance measurement period monthly after the portfolio is fully invested in the composite strategy prior monthly periods reflect a policy of at least one full reporting period under management before a new portfolio would be added to the composite returns are denominated in us dollars performance results are shown “gross” and “net” using actual investment management fees all performance shown reflects trade execution costs and assumes the reinvestment of dividends and capital gains percentage returns include portfolios under management that meet the following criteria full discretionary investment authority and follow common investment strategies no selective periods for presentation have been utilized effective  the extended small cap value equity composite changed its name to smid cap value there have been no changes in the process philosophy or team only a change of name a complete list and description of all composites maintained by northpointe and the related performance results as well as additional information regarding policies for valuing portfolios calculating performance and preparing compliant presentations are available upon request as of   of composite are non fee paying a complete list and description of all composites maintained by northpointe and the related performance results as well as additional information regarding policies for valuing portfolios calculating performance and preparing compliant presentations are available upon request composite dispersion measures represent the consistency of a firm’s composite performance with respect to the individual portfolio returns within a composite the dispersion of annual returns is measured by the equal weighted standard deviation of portfolios in the composite for the entire year nm – statistical measures of internal dispersions for composites with five or fewer accounts are considered not meaningful na – year annualized expost standard deviation is not presented because  monthly returns are not available the russell ® index is published by russell investments the russell ® index measures the performance of the smallcap segment of the us equity universe the russell ® index is a subset of the russell ® index representing approximately  of the total market capitalization of that index it includes approximately  of the smallest securities based on a combination of their market cap and current index membership the russell ® value index is published by russell investments the russell ® value index measures the performance of the largecap value segment of the us equity universe it includes those russell ® companies with lower pricetobook ratios and lower expected growth values the russell  index measures the performance of the largecap segment of the us equity universe it is a subset of the russell ® index and includes approximately  of the largest securities based on a combination of their market cap and current index membership the russell  represents approximately  of the us market the russell microcap® value index is published by russell investments the russell microcap® value index measures the performance of the microcap value segment of the us equity market it includes those russell microcap® index companies with lower pricetobook ratios and lower forecasted growth values the russell microcap® index measures the performance of the microcap segment of the us equity market it makes up less than  of the us equity market it includes  of the smallest securities in the smallcap russell ® index based on a combination of their market cap and current index membership and it includes the next  securities the russell ® value index and the russell ® index are published by russell investments the russell ® value index measures the performance of smallcap value segment of the us equity universe it includes those russell ® companies with lower pricetobook ratios and lower forecasted growth values the russell ® index measures the performance of the smallcap segment of the us equity universe the russell ® index is a subset of the russell ® index representing approximately  of the total market capitalization of that index it includes approximately  of the smallest securities based on a combination of their market cap and current index membership the russell ™ value index and the russell ™ index are published by russell investments the russell ™ value index measures the performance of the small to midcap value segment of the us equity universe it includes those russell ™ companies with lower pricetobook ratios and lower forecasted growth values the russell ™ index measures the performance of the small to midcap segment of the us equity universe commonly referred to as “smid” cap the russell ™ index is a subset of the russell ® index it includes approximately  of the smallest securities based on a combination of their market cap and current index membership our strategies valuevalue large cap value equity smid cap value equity small cap value equity micro cap value equity opportunisticopportunistic concentrated small cap small cap core other resource downloads our adv brochure our composite listings gips disclosures micro cap whitepaper download our whitepapers learn more about the benefits of micro cap and large cap investing email address namethis field is for validation purposes and should be left unchanged reach out to us  woodward ave ste  bloomfield hills mi  phone  contact us northpointe on linkedin abbott laboratories nyseabt stock price news  analysis abbott laboratories company profile nyseabt company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about abbott laboratories nyseabt abbott laboratories is engaged in the discovery development manufacture and sale of a range of healthcare products the company operates through four segments established pharmaceutical products diagnostic products nutritional products and vascular products its established pharmaceutical products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the united states its diagnostic products include a range of diagnostic systems and tests its nutritional products include a range of pediatric and adult nutritional products its companys vascular products include a range of coronary endovascular vessel closure and structural heart devices for the treatment of vascular disease the company through st jude medical inc also offers products such as rhythm management products electrophysiology products heart failure related products vascular products structural heart products and neuromodulation products industry sector and symbol sector medical industry pharmaceuticals  nec subindustry health care equipment symbol nyseabt cusip  web wwwabbottcom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividendannual dividend dividend yield  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  million shsbeta short ratio    frequently asked questions for abbott laboratories nyseabt what is abbott laboratories stock symbol abbott laboratories trades on the new york stock exchange nyse under the ticker symbol abt how often does abbott laboratories pay dividends what is the dividend yield for abbott laboratories abbott laboratories declared a quarterly dividend on friday june th shareholders of record on friday july th will be given a dividend of  per share on tuesday august th this represents a  dividend on an annualized basis and a yield of  the exdividend date is wednesday july th view abbott laboratories dividend history how were abbott laboratories earnings last quarter abbott laboratories nyseabt released its quarterly earnings results on thursday july th the company reported  eps for the quarter topping the consensus estimate of  by  the company had revenue of  billion for the quarter compared to analyst estimates of  billion abbott laboratories had a net margin of  and a return on equity of  the companys revenue was up  compared to the same quarter last year during the same period in the previous year the company posted  eps view abbott laboratories earnings history when will abbott laboratories make its next earnings announcement abbott laboratories is scheduled to release their next quarterly earnings announcement on tuesday october th  view earnings estimates for abbott laboratories what guidance has abbott laboratories issued on next quarters earnings abbott laboratories updated its third quarter earnings guidance on thursday july th the company provided eps guidance of  for the period compared to the thomson reuters consensus earnings per share estimate of  abbott laboratories also updated its fy guidance to  eps where is abbott laboratories stock going where will abbott laboratories stock price be in   brokerages have issued  month price objectives for abbott laboratories stock their forecasts range from  to  on average they expect abbott laboratories stock price to reach  in the next year view analyst ratings for abbott laboratories what are analysts saying about abbott laboratories stock here are some recent quotes from research analysts about abbott laboratories stock  according to zacks investment research for the majority of last one month abbott is trading above the broader medical products industry we are optimistic about the company’s strong and consistent epd and medical devices performance in the last reported first quarter overall the company stands to benefit from the ongoing integration and synergy achievement of st jude we are also looking forward to the company’s plans to focus on selling portfolio in core therapeutic areas recently abbott received ce mark for its tacticath sensor and confirm rx icm products which is quite encouraging the company also launched sciencebased nutrition drinks for better recovery from surgeries on the flip side abbott’s sluggish pediatric business in china continues to hamper growth management is also concerned about the ongoing economic problem in venezuela that is expected to remain unresolved in the coming quarters   jefferies group llc analysts commented investment summary we are reiterating our overweight rating for cori and we are raising our pt by  to  following the positive donepezil patch bioequivalence results progress in the development of a proprietary pipeline is key in our opinion to the performance of the shares successful development of patch formulations of donepezil aricept andor memantine namenda should position the company well to moreeffectively monetize the transdermal drug delivery platform in our opinion retention of meaningful commercialization rights could enable the company to turn the corner and pursue other opportunities more broadly in our opinion corplex donepezil pilot study shows bioequivalence management reported that the corplex donepezil pilot study met the fda statistical criteria for bioequivalence we note too that the patch was welltolerated with good skin and gi tolerability  who are some of abbott laboratories key competitors some companies that are related to abbott laboratories include merck  co mrk sanofi sny novo nordisk as nvo glaxosmithkline plc gsk bristolmyers squibb company bmy eli lilly and company lly astrazeneca plc azn glaxosmithkline plc gsk astrazeneca plc azn shire plc shpg shire plc shp teva pharmaceutical industries limited teva dr reddys laboratories ltd rdy valeant pharmaceuticals international vrx patheon nv pthn taro pharmaceutical industries taro catalent ctlt and akorn akrx who are abbott laboratories key executives abbott laboratories management team includes the folowing people miles d white chairman of the board chief executive officerbrian b yoor chief financial officer senior vice president  financemichael t rousseau president  cardiovascular and neuromodulationhubert l allen executive vice president general counsel secretarystephen r fussell executive vice president  human resourcesbrian j blaser executive vice president  diagnostics productsjohn m capek phd executive vice president  venturesrobert b ford executive vice president  medical devicesheather l mason executive vice president  nutritional productsroger bird senior vice president  us nutrition who owns abbott laboratories stock abbott laboratories stock is owned by a variety of of retail and institutional investors top institutional investors include vontobel asset management inc  us bancorp de  rockefeller financial services inc  jarislowsky fraser ltd  nn investment partners holdings nv  and apg asset management nv  company insiders that own abbott laboratories stock include brian b yoor brian j blaser daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jaime contreras jared watkin joseph j manning michael j warmuth miles d white robert b ford robert e funck roger bird sally e blount and stephen r fussell view institutional ownership trends for abbott laboratories who sold abbott laboratories stock who is selling abbott laboratories stock abbott laboratories stock was sold by a variety of institutional investors in the last quarter including dnb asset management as apg asset management nv bank of montreal can vontobel asset management inc hermes investment management ltd nn investment partners holdings nv rockefeller financial services inc and miller howard investments inc ny company insiders that have sold abbott laboratories stock in the last year include daniel gesua sive salvadori deepak s nath heather l mason jared watkin joseph j manning michael j warmuth robert e funck roger bird and stephen r fussell view insider buying and selling for abbott laboratories who bought abbott laboratories stock who is buying abbott laboratories stock abbott laboratories stock was purchased by a variety of institutional investors in the last quarter including hexavest inc fisher asset management llc mn services vermogensbeheer bv national pension service pennsylvania trust co aperio group llc sit investment associates inc and jarislowsky fraser ltd company insiders that have bought abbott laboratories stock in the last two years include brian j blaser miles d white robert b ford and sally e blount view insider buying and selling for abbott laboratories how do i buy abbott laboratories stock shares of abbott laboratories can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is abbott laboratories stock price today one share of abbott laboratories stock can currently be purchased for approximately  marketbeat community rating for abbott laboratories nyse abtcommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about abbott laboratories and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for abbott laboratories nyseabt how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for abbott laboratories nyseabt show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsbarclays plcreiterated ratingoverweight  lowstifel nicolausreiterated ratingbuylowcowen and companyreiterated ratingoutperform  lowbmo capital marketsreiterated ratingholdlowmorgan stanleyreiterated ratingequal weightlowwells fargo  companyreiterated ratingoutperform  lowjefferies group llcreiterated ratingbuylowguggenheiminitiated coveragebuylowbtig researchinitiated coveragebuylowgoldman sachs group inc theinitiated coverageneutral  neutrallowroyal bank of canadareiterated ratingbuylowbank of america corporationreiterated ratingbuynadeutsche bank agreiterated ratingbuynaargusreiterated ratingbuynaedward jonesupgradehold  buynacredit suisse groupreiterated ratingbuynasp equity researchreiterated ratingholdnagabellireiterated ratingbuynapiper jaffray companiesdowngradeoverweight  neutralnafirst globaldowngradeoutperform  marketperformnaleerink swannboost price targetmarket perform  naraymond james financial inclower price targetoutperform  nawilliam blairdowngradeoutperform  market performnadata available from  forward earnings earnings history for abbott laboratories nyseabtearnings history by quarter for abbott laboratories nyse abtdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsnaq  billion billionviewna billion billionviewnaq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenviewnaviewnaviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for abbott laboratories nyseabt eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends current dividend information for abbott laboratories nyseabtnext dividendannual dividenddividend yielddividend growth  year averagepayout ratio trailing  months of earnings  based on this years estimates based on next years estimatestrack record years of consecutive dividend growthdividend history by quarter for abbott laboratories nyse abtannouncedperiodamountyieldexdividend daterecord datepayable datequarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlydata available from  forward insider trades insider trading and institutional ownership history for abbott laboratories nyseabtinsider ownership percentage institutional ownership percentage insider trades by quarter for abbott laboratories nyseabttransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsjared watkininsidersell  stephen r fussellinsidersell  roger birdinsidersell  joseph j manninginsidersell  michael j warmuthinsidersell  robert e funckvpsell  roger birdinsidersell  deepak s nathinsidersell  heather l masoninsidersell  brian j blaserinsiderbuy  robert b fordinsiderbuy  miles d whitechairmanbuy  sally e blountdirectorbuy  daniel gesua sive salvadorisvpsell  stephen r fussellinsidersell  michael j warmuthinsidersell  miles d whitechairmanbuy  robert e funckvpsell  hubert l allenevpsell  jared watkinsvpsell  brian b yoorcfosell  deepak s nathsvpsell  jaime contrerassvpsell  brian b yoorcfosell  deepak s nathsvpsell  robert b fordevpsell  robert e funckvpsell  jared watkinsvpsell  deepak s nathsvpsell  miles d whiteceosell  stephen r fussellevpsell  heather l masonevpsell  roger birdsvpsell  j scott whitesvpsell  jaime contrerassvpsell  john m capekevpsell  jaime contrerassvpsell  miles d whiteceosell  john landgrafevpsell  katherine doylesvpsell  robert funckvpsell  john landgrafevpsell  michael warmuthevpsell  jeanyves paveesvpsell  stephen fussellevpsell  jaime contrerassvpsell  heather l masonsvpsell  william a osborndirectorbuy  data available from  forward headlines headline trends for abbott laboratories nyseabt latest headlines for abbott laboratories nyseabt source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineabiomed expects to expand its presence in this spacefinanceyahoocom  july  at  pmfy earnings estimate for abbott laboratories abt issued by gabelliwwwamericanbankingnewscom  july  at  amabbott laboratories expected to post fy earnings of  per share nyseabtwwwamericanbankingnewscom  july  at  amfy earnings estimate for abbott laboratories abt issued by william blairwwwamericanbankingnewscom  july  at  amjefferies group comments on abbott laboratories q  earnings abtwwwamericanbankingnewscom  july  at  amabbott laboratories nyseabt expected to post quarterly sales of  billionwwwamericanbankingnewscom  july  at  pmabbott laboratories abt overweight rating reaffirmed at barclays plcwwwamericanbankingnewscom  july  at  pmabbott labs abt pt raised to  at argus on q beat  fy raise positive view of growth prospects  streetinsidercomwwwstreetinsidercom  july  at  pmabbott labs abt pt raised to  at barclays on q beat  fy eps raise h outlook appears bright  streetinsidercomwwwstreetinsidercom  july  at  pmabbott laboratories abt buy rating reaffirmed at stifel nicolauswwwamericanbankingnewscom  july  at  pmtodays research reports on stocks to watch abbott laboratories and pfizer incfinanceyahoocom  july  at  pmcompany news for july  financeyahoocom  july  at  pmbehind the major drivers of jnj’s medical device growthfinanceyahoocom  july  at  pmabbott laboratories nyseabt price target raised to  at arguswwwamericanbankingnewscom  july  at  pmdeutsche bank ag increases abbott laboratories abt price target to wwwamericanbankingnewscom  july  at  pmzacks brokerages anticipate abbott laboratories nyseabt to announce  epswwwamericanbankingnewscom  july  at  amabbott q profit falls but results top view lifts  profit outlookwwwrttnewscom  july  at  amlabcorp lh q earnings is disappointment in the cardsfinanceyahoocom  july  at  pmabbott laboratories abt releases q earnings guidancewwwamericanbankingnewscom  july  at  pmabbott labs abt beats on q earnings and sales view up  nasdaqwwwnasdaqcom  july  at  pmabbott abt tops earnings estimates in q misses on salesfinanceyahoocom  july  at  pmus stockswall st flat as earnings from some big names disappointfinanceyahoocom  july  at  pmabbott zeros in on a year high after topping q sales profitsfinanceyahoocom  july  at  pmus stockswall st flat as consumer stocks weak earnings weighfinanceyahoocom  july  at  pmabbott ceo another alererelated divestiture coming soonfinanceyahoocom  july  at  pmabbott labs abt beats on q earnings and sales view upfinanceyahoocom  july  at  pmabbott profit forecast gets a lift from st jude integrationfinanceyahoocom  july  at  pmabbott tops street q forecastsfinanceyahoocom  july  at  pmus stockssp dow flat as retailers weigh nasdaq edges higherfinanceyahoocom  july  at  pmabbott laboratories abt releases earnings resultswwwamericanbankingnewscom  july  at  amabbott laboratories abt releases fy earnings guidancewwwamericanbankingnewscom  july  at  amwhat to watch for in abbotts q earnings  nasdaqwwwnasdaqcom  july  at  pmmedical product stocks earnings on jul  abt isrg  more  nasdaqwwwnasdaqcom  july  at  pmabbott laboratories nyseabt american express company   benzingawwwbenzingacom  july  at  pmquidel diversifies with aleres triage assets  thestreetcomwwwthestreetcom  july  at  pmquidel diversifies with aleres triage assetsfinanceyahoocom  july  at  pmrisk arbitrage today  ma deals that had price cuts with a little meat left on the boneseekingalphacom  july  at  pmabbotts tarnished deal sparkles for anotherfinanceyahoocom  july  at  pmcan abbott laboratories abt pull a surprise in q earnings  nasdaqwwwnasdaqcom  july  at  amcan abbott laboratories abt pull a surprise in q earningsfinanceyahoocom  july  at  pmearnings roundup jnj ibm and lmt report q results tomorrow  benzingawwwbenzingacom  july  at  pmscience sugar substitute effects not so sweetfinanceyahoocom  july  at  pmcorporate america is about to unleash great earnings reports hopefully week ahead  thestreetcomwwwthestreetcom  july  at  amabbott labs abt pt raised to  at cowen refining sales   streetinsidercomwwwstreetinsidercom  july  at  pmabt wall street analysts’ recommendations ahead of q earningsfinanceyahoocom  july  at  pmwill abbott laboratories beat analyst revenue estimates in qfinanceyahoocom  july  at  pmwhat to expect from abbott laboratories’ q earningsfinanceyahoocom  july  at  pmcowen and company reiterates outperform rating for abbott laboratories abtwwwamericanbankingnewscom  july  at  pmtraders buy large volume of abbott laboratories call options nyseabtwwwamericanbankingnewscom  july  at  amabbott teams up with bigfoot bio in diabetes management  seeking alphaseekingalphacom  july  at  am social chart abbott laboratories abt chart for monday july   this page was last updated on  by marketbeatcom staff abbott laboratories nyseabt stock price news  analysis abbott laboratories company profile nyseabt company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about abbott laboratories nyseabt abbott laboratories is engaged in the discovery development manufacture and sale of a range of healthcare products the company operates through four segments established pharmaceutical products diagnostic products nutritional products and vascular products its established pharmaceutical products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the united states its diagnostic products include a range of diagnostic systems and tests its nutritional products include a range of pediatric and adult nutritional products its companys vascular products include a range of coronary endovascular vessel closure and structural heart devices for the treatment of vascular disease the company through st jude medical inc also offers products such as rhythm management products electrophysiology products heart failure related products vascular products structural heart products and neuromodulation products industry sector and symbol sector medical industry pharmaceuticals  nec subindustry health care equipment symbol nyseabt cusip  web wwwabbottcom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividendannual dividend dividend yield  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  million shsbeta short ratio    frequently asked questions for abbott laboratories nyseabt what is abbott laboratories stock symbol abbott laboratories trades on the new york stock exchange nyse under the ticker symbol abt how often does abbott laboratories pay dividends what is the dividend yield for abbott laboratories abbott laboratories announced a quarterly dividend on friday june th shareholders of record on friday july th will be paid a dividend of  per share on tuesday august th this represents a  annualized dividend and a yield of  the exdividend date is wednesday july th view abbott laboratories dividend history how were abbott laboratories earnings last quarter abbott laboratories nyseabt issued its quarterly earnings data on thursday july th the company reported  earnings per share eps for the quarter beating the consensus estimate of  by  the company earned  billion during the quarter compared to analyst estimates of  billion abbott laboratories had a net margin of  and a return on equity of  the companys revenue for the quarter was up  on a yearoveryear basis during the same period in the prior year the firm posted  earnings per share view abbott laboratories earnings history when will abbott laboratories make its next earnings announcement abbott laboratories is scheduled to release their next quarterly earnings announcement on tuesday october th  view earnings estimates for abbott laboratories what guidance has abbott laboratories issued on next quarters earnings abbott laboratories issued an update on its third quarter earnings guidance on thursday july th the company provided earnings per share guidance of  for the period compared to the thomson reuters consensus estimate of  abbott laboratories also updated its fy guidance to  eps where is abbott laboratories stock going where will abbott laboratories stock price be in   brokers have issued twelvemonth price objectives for abbott laboratories stock their predictions range from  to  on average they expect abbott laboratories share price to reach  in the next twelve months view analyst ratings for abbott laboratories what are analysts saying about abbott laboratories stock here are some recent quotes from research analysts about abbott laboratories stock  according to zacks investment research for the majority of last one month abbott is trading above the broader medical products industry we are optimistic about the company’s strong and consistent epd and medical devices performance in the last reported first quarter overall the company stands to benefit from the ongoing integration and synergy achievement of st jude we are also looking forward to the company’s plans to focus on selling portfolio in core therapeutic areas recently abbott received ce mark for its tacticath sensor and confirm rx icm products which is quite encouraging the company also launched sciencebased nutrition drinks for better recovery from surgeries on the flip side abbott’s sluggish pediatric business in china continues to hamper growth management is also concerned about the ongoing economic problem in venezuela that is expected to remain unresolved in the coming quarters   jefferies group llc analysts commented investment summary we are reiterating our overweight rating for cori and we are raising our pt by  to  following the positive donepezil patch bioequivalence results progress in the development of a proprietary pipeline is key in our opinion to the performance of the shares successful development of patch formulations of donepezil aricept andor memantine namenda should position the company well to moreeffectively monetize the transdermal drug delivery platform in our opinion retention of meaningful commercialization rights could enable the company to turn the corner and pursue other opportunities more broadly in our opinion corplex donepezil pilot study shows bioequivalence management reported that the corplex donepezil pilot study met the fda statistical criteria for bioequivalence we note too that the patch was welltolerated with good skin and gi tolerability  who are some of abbott laboratories key competitors some companies that are related to abbott laboratories include merck  co mrk sanofi sny novo nordisk as nvo glaxosmithkline plc gsk bristolmyers squibb company bmy eli lilly and company lly astrazeneca plc azn glaxosmithkline plc gsk astrazeneca plc azn shire plc shpg shire plc shp teva pharmaceutical industries limited teva dr reddys laboratories ltd rdy valeant pharmaceuticals international vrx patheon nv pthn taro pharmaceutical industries taro catalent ctlt and akorn akrx who are abbott laboratories key executives abbott laboratories management team includes the folowing people miles d white chairman of the board chief executive officerbrian b yoor chief financial officer senior vice president  financemichael t rousseau president  cardiovascular and neuromodulationhubert l allen executive vice president general counsel secretarystephen r fussell executive vice president  human resourcesbrian j blaser executive vice president  diagnostics productsjohn m capek phd executive vice president  venturesrobert b ford executive vice president  medical devicesheather l mason executive vice president  nutritional productsroger bird senior vice president  us nutrition who owns abbott laboratories stock abbott laboratories stock is owned by a number of of institutional and retail investors top institutional shareholders include vontobel asset management inc  us bancorp de  rockefeller financial services inc  jarislowsky fraser ltd  nn investment partners holdings nv  and apg asset management nv  company insiders that own abbott laboratories stock include brian b yoor brian j blaser daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jaime contreras jared watkin joseph j manning michael j warmuth miles d white robert b ford robert e funck roger bird sally e blount and stephen r fussell view institutional ownership trends for abbott laboratories who sold abbott laboratories stock who is selling abbott laboratories stock abbott laboratories stock was sold by a variety of institutional investors in the last quarter including dnb asset management as apg asset management nv bank of montreal can vontobel asset management inc hermes investment management ltd nn investment partners holdings nv rockefeller financial services inc and miller howard investments inc ny company insiders that have sold abbott laboratories stock in the last year include daniel gesua sive salvadori deepak s nath heather l mason jared watkin joseph j manning michael j warmuth robert e funck roger bird and stephen r fussell view insider buying and selling for abbott laboratories who bought abbott laboratories stock who is buying abbott laboratories stock abbott laboratories stock was purchased by a variety of institutional investors in the last quarter including hexavest inc fisher asset management llc mn services vermogensbeheer bv national pension service pennsylvania trust co aperio group llc sit investment associates inc and jarislowsky fraser ltd company insiders that have bought abbott laboratories stock in the last two years include brian j blaser miles d white robert b ford and sally e blount view insider buying and selling for abbott laboratories how do i buy abbott laboratories stock shares of abbott laboratories can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is abbott laboratories stock price today one share of abbott laboratories stock can currently be purchased for approximately  marketbeat community rating for abbott laboratories nyse abtcommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about abbott laboratories and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for abbott laboratories nyseabt how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for abbott laboratories nyseabt show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsbarclays plcreiterated ratingoverweight  lowstifel nicolausreiterated ratingbuylowcowen and companyreiterated ratingoutperform  lowbmo capital marketsreiterated ratingholdlowmorgan stanleyreiterated ratingequal weightlowwells fargo  companyreiterated ratingoutperform  lowjefferies group llcreiterated ratingbuylowguggenheiminitiated coveragebuylowbtig researchinitiated coveragebuylowgoldman sachs group inc theinitiated coverageneutral  neutrallowroyal bank of canadareiterated ratingbuylowbank of america corporationreiterated ratingbuynadeutsche bank agreiterated ratingbuynaargusreiterated ratingbuynaedward jonesupgradehold  buynacredit suisse groupreiterated ratingbuynasp equity researchreiterated ratingholdnagabellireiterated ratingbuynapiper jaffray companiesdowngradeoverweight  neutralnafirst globaldowngradeoutperform  marketperformnaleerink swannboost price targetmarket perform  naraymond james financial inclower price targetoutperform  nawilliam blairdowngradeoutperform  market performnadata available from  forward earnings earnings history for abbott laboratories nyseabtearnings history by quarter for abbott laboratories nyse abtdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsnaq  billion billionviewna billion billionviewnaq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenviewnaviewnaviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for abbott laboratories nyseabt eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends current dividend information for abbott laboratories nyseabtnext dividendannual dividenddividend yielddividend growth  year averagepayout ratio trailing  months of earnings  based on this years estimates based on next years estimatestrack record years of consecutive dividend growthdividend history by quarter for abbott laboratories nyse abtannouncedperiodamountyieldexdividend daterecord datepayable datequarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlydata available from  forward insider trades insider trading and institutional ownership history for abbott laboratories nyseabtinsider ownership percentage institutional ownership percentage insider trades by quarter for abbott laboratories nyseabttransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsjared watkininsidersell  stephen r fussellinsidersell  roger birdinsidersell  joseph j manninginsidersell  michael j warmuthinsidersell  robert e funckvpsell  roger birdinsidersell  deepak s nathinsidersell  heather l masoninsidersell  brian j blaserinsiderbuy  robert b fordinsiderbuy  miles d whitechairmanbuy  sally e blountdirectorbuy  daniel gesua sive salvadorisvpsell  stephen r fussellinsidersell  michael j warmuthinsidersell  miles d whitechairmanbuy  robert e funckvpsell  hubert l allenevpsell  jared watkinsvpsell  brian b yoorcfosell  deepak s nathsvpsell  jaime contrerassvpsell  brian b yoorcfosell  deepak s nathsvpsell  robert b fordevpsell  robert e funckvpsell  jared watkinsvpsell  deepak s nathsvpsell  miles d whiteceosell  stephen r fussellevpsell  heather l masonevpsell  roger birdsvpsell  j scott whitesvpsell  jaime contrerassvpsell  john m capekevpsell  jaime contrerassvpsell  miles d whiteceosell  john landgrafevpsell  katherine doylesvpsell  robert funckvpsell  john landgrafevpsell  michael warmuthevpsell  jeanyves paveesvpsell  stephen fussellevpsell  jaime contrerassvpsell  heather l masonsvpsell  william a osborndirectorbuy  data available from  forward headlines headline trends for abbott laboratories nyseabt latest headlines for abbott laboratories nyseabt source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineabiomed expects to expand its presence in this spacefinanceyahoocom  july  at  pmfy earnings estimate for abbott laboratories abt issued by gabelliwwwamericanbankingnewscom  july  at  amabbott laboratories expected to post fy earnings of  per share nyseabtwwwamericanbankingnewscom  july  at  amfy earnings estimate for abbott laboratories abt issued by william blairwwwamericanbankingnewscom  july  at  amjefferies group comments on abbott laboratories q  earnings abtwwwamericanbankingnewscom  july  at  amabbott laboratories nyseabt expected to post quarterly sales of  billionwwwamericanbankingnewscom  july  at  pmabbott laboratories abt overweight rating reaffirmed at barclays plcwwwamericanbankingnewscom  july  at  pmabbott labs abt pt raised to  at argus on q beat  fy raise positive view of growth prospects  streetinsidercomwwwstreetinsidercom  july  at  pmabbott labs abt pt raised to  at barclays on q beat  fy eps raise h outlook appears bright  streetinsidercomwwwstreetinsidercom  july  at  pmabbott laboratories abt buy rating reaffirmed at stifel nicolauswwwamericanbankingnewscom  july  at  pmtodays research reports on stocks to watch abbott laboratories and pfizer incfinanceyahoocom  july  at  pmcompany news for july  financeyahoocom  july  at  pmbehind the major drivers of jnj’s medical device growthfinanceyahoocom  july  at  pmabbott laboratories nyseabt price target raised to  at arguswwwamericanbankingnewscom  july  at  pmdeutsche bank ag increases abbott laboratories abt price target to wwwamericanbankingnewscom  july  at  pmzacks brokerages anticipate abbott laboratories nyseabt to announce  epswwwamericanbankingnewscom  july  at  amabbott q profit falls but results top view lifts  profit outlookwwwrttnewscom  july  at  amlabcorp lh q earnings is disappointment in the cardsfinanceyahoocom  july  at  pmabbott laboratories abt releases q earnings guidancewwwamericanbankingnewscom  july  at  pmabbott labs abt beats on q earnings and sales view up  nasdaqwwwnasdaqcom  july  at  pmabbott abt tops earnings estimates in q misses on salesfinanceyahoocom  july  at  pmus stockswall st flat as earnings from some big names disappointfinanceyahoocom  july  at  pmabbott zeros in on a year high after topping q sales profitsfinanceyahoocom  july  at  pmus stockswall st flat as consumer stocks weak earnings weighfinanceyahoocom  july  at  pmabbott ceo another alererelated divestiture coming soonfinanceyahoocom  july  at  pmabbott labs abt beats on q earnings and sales view upfinanceyahoocom  july  at  pmabbott profit forecast gets a lift from st jude integrationfinanceyahoocom  july  at  pmabbott tops street q forecastsfinanceyahoocom  july  at  pmus stockssp dow flat as retailers weigh nasdaq edges higherfinanceyahoocom  july  at  pmabbott laboratories abt releases earnings resultswwwamericanbankingnewscom  july  at  amabbott laboratories abt releases fy earnings guidancewwwamericanbankingnewscom  july  at  amwhat to watch for in abbotts q earnings  nasdaqwwwnasdaqcom  july  at  pmmedical product stocks earnings on jul  abt isrg  more  nasdaqwwwnasdaqcom  july  at  pmabbott laboratories nyseabt american express company   benzingawwwbenzingacom  july  at  pmquidel diversifies with aleres triage assets  thestreetcomwwwthestreetcom  july  at  pmquidel diversifies with aleres triage assetsfinanceyahoocom  july  at  pmrisk arbitrage today  ma deals that had price cuts with a little meat left on the boneseekingalphacom  july  at  pmabbotts tarnished deal sparkles for anotherfinanceyahoocom  july  at  pmcan abbott laboratories abt pull a surprise in q earnings  nasdaqwwwnasdaqcom  july  at  amcan abbott laboratories abt pull a surprise in q earningsfinanceyahoocom  july  at  pmearnings roundup jnj ibm and lmt report q results tomorrow  benzingawwwbenzingacom  july  at  pmscience sugar substitute effects not so sweetfinanceyahoocom  july  at  pmcorporate america is about to unleash great earnings reports hopefully week ahead  thestreetcomwwwthestreetcom  july  at  amabbott labs abt pt raised to  at cowen refining sales   streetinsidercomwwwstreetinsidercom  july  at  pmabt wall street analysts’ recommendations ahead of q earningsfinanceyahoocom  july  at  pmwill abbott laboratories beat analyst revenue estimates in qfinanceyahoocom  july  at  pmwhat to expect from abbott laboratories’ q earningsfinanceyahoocom  july  at  pmcowen and company reiterates outperform rating for abbott laboratories abtwwwamericanbankingnewscom  july  at  pmtraders buy large volume of abbott laboratories call options nyseabtwwwamericanbankingnewscom  july  at  amabbott teams up with bigfoot bio in diabetes management  seeking alphaseekingalphacom  july  at  am social chart abbott laboratories abt chart for monday july   this page was last updated on  by marketbeatcom staff north pointe capital llc  w big beaver rd troy mi investments  mapquest north pointe capital llc  w big beaver rd troy mi  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  sponsored topics see a problem let us know northpointe capital llc is a domesticequity money management firm catering to the investment needs of institutions and individuals based in troy mich it provides solutions in the areas of investments trading compliance information technology marketing and client service decisions the investment strategy of northpointe capital llc combines fundamental research with quantitative analysis emphasizing fundamental analysis in the more inefficient small cap market segment the firms primary strategy composites include focused small cap growth equity and large cap value equity its complementary strategy composites include concentrated small cap equity and microcap core equity legal help northpoint capital llc company profile  bloomberg feedback northpoint capital llc private company company profile sector financials industry specialty finance subindustry mortgage finance northpoint capital llc was founded in  the companys line of business includes originating mortgage loans selling mortgage loans to permanent investors and servicing loans corporate information address  w lake st ste  chicago il  united states phone  fax  web url wwwnorthpointcapitalnet from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data northpointe capital llc the money manager people tm money manager performance research center  research another money manager performance research and ranking for northpointe capital llc updated  money manager reports include performance annually risk reward analysis money manager review money manager ranking heres how it works fill in the form on this page well research our database our wealth managers will prepare your requested reports and maybe a few additional ones your money manager reports will be delivered to you by email request your free reports or call one of our wealth managers for more detailed information  your information is secure  in the meantime heres some basic information about northpointe capital llc company informationnamenorthpointe capital llcaddress w big beaver roadsuite troy mi phonewebsitewwwnorthpointecapitalcomcompany productsextended small cap valuefocused small cap growthlarge cap corelarge cap valuemicro cap growthmid cap growthsmall cap growth equitysmall cap valuesmid cap growth northpointe capital llc commentary  research another money manager any money management or investment advisory firms listed on this website are not related entities of wrapmanager inc and are listed for convenience and informational purposes only the listing of a money manager on this website does not imply a solicitation or recommendation of the money manager wrapmanager inc is responsible only for the content of this website and it has no control over other websites that may be accessible from this website the contents therein or the productsservices offered by third parties hyperlinks to or from this website do not constitute third party endorsement of sponsorship by or affiliation with wrapmanager inc   important disclosure  privacy policy  wrapmanager inc  market street th floor san francisco ca    tollfree     fax  click to email us   wrapmanager inc all rights reserved wrapmanager is an secregistered investment adviser   qualified investors are those with k or more in investable assets